Share Email Print

Proceedings Paper

Glucose-functionalized gold nanoparticles as a metabolically targeted CT contrast agent for distinguishing tumors from non-malignant metabolically active processes
Author(s): Tamar Dreifuss; Menachem Motiei; Oshra Betzer; Aron Popovtzer; Galith Abourbeh; Eyal Mishani; Rachela Popovtzer
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

The highly used cancer imaging technique, [18F]FDG-PET, is based on the increased glucose metabolic activity in tumors. However, since there are other biological processes that exhibit increased metabolic activity, in particular inflammation, this methodology is prone to non-specificity for cancer. Herein we describe the development of a novel nanoparticle-based approach, utilizes Glucose-Functionalized Gold Nanoparticles (GF-GNPs) as a metabolically targeted CT contrast agent. Our method has demonstrated specific tumor targeting and has successfully differentiated between cancer and inflammation in a combined tumor-inflammation mouse model, due to dissimilarities in vasculatures in different pathologic conditions. This novel approach provides new capabilities in cancer imaging, and can be applicable to a wide range of cancers.

Paper Details

Date Published: 22 February 2017
PDF: 9 pages
Proc. SPIE 10077, Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XIV, 100770I (22 February 2017); doi: 10.1117/12.2249850
Show Author Affiliations
Tamar Dreifuss, Bar-Ilan Univ. (Israel)
Menachem Motiei, Bar-Ilan Univ. (Israel)
Oshra Betzer, Bar-Ilan Univ. (Israel)
Aron Popovtzer, Rabin Medical Ctr. (Israel)
Galith Abourbeh, Hadassah-Hebrew Univ. Hospital (Israel)
Eyal Mishani, Hadassah-Hebrew Univ. Hospital (Israel)
Rachela Popovtzer, Bar-Ilan Univ. (Israel)

Published in SPIE Proceedings Vol. 10077:
Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XIV
Alexander N. Cartwright; Dan V. Nicolau; Dror Fixler, Editor(s)

© SPIE. Terms of Use
Back to Top